Adolescents and young adults (AYAs) with cancer represent a unique group with unmet needs. Metrics and quality indicators are important for evaluating AYA cancer care. The purpose of this study is to describe the quality indicators in a Canadian context that are used for AYA (15–39 years of age) cancer care and control. The Arksey and O'Malley methodological framework was applied to undertake a scoping review of the peer-reviewed and gray literature for indicators related to AYA cancer care and control. OVID Medline was searched from January 1995 until April 2018 for English language articles. Inquiries were made to AYA cancer organizations and a Google search conducted to identify unpublished material. Articles were included if they incorporated AYAs and contained cancer care indicators. Data were summarized at the article and indicator level. A total of 610 abstracts were reviewed. Eighty-nine full-text articles and reports were assessed for eligibility, with 19 included in analyses which identified 146 indicators or indicator concepts. Most of the indicators were specific to the AYA age group (65.8%) and dealt with the active care theme (57.5%), almost half focusing on guideline adherence and treatment (26.4%) and multidisciplinary/specialized care (20.7%). Notable deficits in indicators were in fertility, psychosocial care, and prevention. Important progress has been made internationally and within Canada on developing indicators for AYA cancer care and control. However, there is a lack of well-defined AYA-specific cancer care indicators developed through a consensus process.
Get full access to this article
View all access options for this article.
References
1.
FernandezCV, BarrRD. Adolescents and young adults with cancer: an orphaned population. Paediatr Child Health. 2006; 11:103–6.
2.
StevensMC.The ‘Lost Tribe'and the need for a promised land: the challenge of cancer in teenagers and young adults. Eur J Cancer. 2006; 42:280–1.
3.
AubinS, BarrR, RogersP, et al.What should the age range be for AYA oncology?. J Adolesc Young Adult Oncol. 2011; 1:3–10.
4.
Adolescent and Young Adult Oncology Progress Review Group. Closing the gap: research and care imperatives for adolescents and young adults with cancer. A Report from the Adolescent and Young Adult Oncology Progress Review Group. Bethesda, MD: Department of Health and Human Services, National Institutes of Health, National Cancer Institute and the LiveStrong Young Adult Alliance. National Cancer Institute. Accessed October31, 2019 from: https://cancer.gov/types/aya/research/ayao-august-2006.pdf
5.
D'agostinoNM, PenneyA, ZebrackB. Providing developmentally appropriate psychosocial care to adolescent and young adult cancer survivors. Cancer. 2011; 117:2329–34.
6.
BleyerA, BarrR, Hayes-LattinB, et al.The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008; 8:288–98.
7.
StarkD, LewisI. Improving outcomes for teenagers and young adults (TYA) with cancer. Klin Pädiatr. 2013; 225:331–4.
8.
BarrRD.Adolescents, young adults, and cancer—the international challenge. Cancer. 2011; 117:2245–9.
9.
OsbornM, LittleC, BoweringS, OrmeL. Youth cancer services in Australia: development and implementation. International perspectives on AYAO, part 3. J Adolesc Young Adult Oncol. 2013; 2:118–24.
10.
MainzJ.Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003; 15:523–30.
11.
Joint Commission on Accreditation of Healthcare Organizations. Characteristics of clinical indicators. Qual Rev Bull. 1989; 11:330–9.
12.
GreenbergA, AngusH, SullivanT, BrownAD. Development of a set of strategy-based system-level cancer care performance indicators in Ontario, Canada. Int J Qual Health Care. 2005; 17:107–14.
13.
MalinJL, AschSM, KerrEA, McGlynnEA. Evaluating the quality of cancer care: development of cancer quality indicators for a global quality assessment tool. Cancer. 2000; 88:701–7.
14.
SeowH, SnyderCF, ShugarmanLR, et al.Developing quality indicators for cancer end-of-life care: proceedings from a national symposium. Cancer. 2009; 115:3820–9.
15.
FernandezC, FraserGA, FreemanC, et al.Principles and recommendations for the provision of healthcare in Canada to adolescent and young adult-aged cancer patients and survivors. J Adolesc Young Adult Oncol. 2011; 1:53–9.
16.
RogersPC, De PauwS, SchacterB, BarrRD. A process for change in the care of adolescents and young adults with cancer inCanada.“Moving to Action”: the Second Canadian InternationalWorkshop.International Perspectives on AYAO, part 1. JAYAO, 2013; 2:72–6.
17.
System Performance Group of the Canadian Task Force on Adolescent and Young Adults with Cancer. Adolescents and young adults with cancer: technical report. Toronto, Canada: Canadian Partnership Against Cancer; April 2017.
18.
ArkseyH, O'MalleyL. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005; 8:19–32.
19.
BradleyNM, RobinsonPD, GreenbergML, et al.Measuring the quality of a childhood cancer care delivery system: assessing stakeholder agreement. Value Health. 2013; 16:639–46.
20.
BradleyNM, RobinsonPD, GreenbergML, et al.Measuring the quality of a childhood cancer care delivery system: quality indicator development. Value Health. 2013; 16:647–54.
21.
GreenbergM, KlassenA, GafniA, et al.Outcomes and metrics: measuring the impact of a comprehensive adolescent and young adult cancer program. Cancer. 2011; 117:2342–50.
Clinical Oncological Society of Australia. Report of the Adolescent and Young Adult (AYA) Cancer Workshop: Clinical Oncological Society of Australia, Camperdown, Auatralia; 21 November 2008.
24.
RonnR, HolzerH. Oncofertility in Canada: the impact of cancer on fertility. Curr Oncol. 2013; 20:e338.
25.
RonnR, HolzerH. Oncofertility in Canada: an overview of Canadian practice and suggested action plan. Curr Oncol. 2013; 20:e465.
26.
RonnR, HolzerH. Oncofertility in Canada: gonadal protection and fertility-sparing strategies. Curr Oncol. 2013; 20:e602.
27.
RonnR, HolzerH. Oncofertility in Canada: cryopreservation and alternative options for future parenthood. Curr Oncol. 2014; 21:e137.
28.
BellizziKM, SmithA, SchmidtS, et al.Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult. Cancer. 2012; 118:5155–62.
29.
EvanEE, ZeltzerLK. Psychosocial dimensions of cancer in adolescents and young adults. Cancer. 2006; 107:1663–71.
30.
ZebrackBJ, CorbettV, EmbryL, et al.Psychological distress and unsatisfied need for psychosocial support in adolescent and young adult cancer patients during the first year following diagnosis. Psychooncology. 2014; 23:1267–75.
31.
BultzBD, GroffSL, FitchM, et al.Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology. 2011; 20:463–9.
32.
BultzBD, HollandJC. Emotional distress in patients with cancer: the sixth vital sign. Commun Oncol. 2006; 3:311–4.
33.
BultzBD, JohansenC. Screening for distress, the 6th vital sign: where are we, and where are we going?. Psychooncology. 2011; 20:569–71.
PalmerS, PattersonP, ThompsonK. A national approach to improving adolescent and young adult (AYA) oncology psychosocial care: the development of AYA-specific psychosocial assessment and care tools. Palliat Support Care. 2014; 12:183–88.
36.
WakefieldCE, PattersonP, McDonaldFE, et al.Assessment of psychosocial outcomes in adolescents and young adults with cancer: a systematic review of available instruments. Clin Oncol Adolesc Young Adults. 2013; 2013:13–27.
37.
BleyerA, BuddT, MontelloM. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006; 107:1645–55.
38.
WallP, MooreC, El-TamerM, ReillyJJ. Diagnostic delay in breast disease: a system analysis of a public urban hospital. Arch Surg. 1998; 133:662–6.
39.
OlayaW, WongJ, MorganJW, et al.Factors associated with variance in compliance with a sentinel lymph node dissection quality measure in early-stage breast cancer. Ann Surg Oncol. 2010; 17:297–302.
40.
de CamargoB, de Oliveira SantosM, RebeloMS, et al.Cancer incidence among children and adolescents in Brazil: first report of 14 population-based cancer registries. Int J Cancer. 2010; 126:715–20.
41.
MarnitzS, KöhlerC, AffonsoRJ, et al.Validity of laparoscopic staging to avoid adjuvant chemoradiation following radical surgery in patients with early cervical cancer. Oncology. 2012; 83:346–53.
42.
VlayenJ, VrijensF, DevrieseS, et al.Quality indicators for testicular cancer: a population-based study. Eur J Cancer. 2012; 48:1133–40.
43.
BristowRE, ChangJ, ZiogasA, Anton-CulverH. Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol. 2013; 121:1226–34.
44.
DeckerKM, McLachlinCM, LotockiR, NetworkP-CCCS, GroupMPPW. Performance measures related to colposcopy for Canadian cervical cancer screening programs: identifying areas for improvement. J Obstet Gynaecol Can. 2015; 37:245–51.
45.
DasenbrockHH, LiuKX, DevineCA, et al.Length of hospital stay after craniotomy for tumor: a National Surgical Quality Improvement Program analysis. Neurosurg Focus. 2015; 39:E12.
46.
ForsbergA, HammarU, EkbomA, HultcrantzR. Post-colonoscopy colorectal cancers in Sweden: room for quality improvement. Eur J Gastroenterol Hepatol. 2017; 29:855–60.
47.
DasenbrockHH, YanSC, SmithTR, et al.Readmission after craniotomy for tumor: a national surgical quality improvement program analysis. Neurosurgery. 2017; 80:551–62.
48.
RoosDE, TeeHC. Quality indicators for early stage Hodgkin's lymphoma. J Med Imaging Radiat Oncol. 2017; 61:550–6.
49.
SuS, BaoH, WangX, et al.The quality of invasive breast cancer care for low reimbursement rate patients: a retrospective study. PLoS One. 2017; 12:e0184866.
50.
PucciarelliS, ZorziM, GennaroN, et al.In-hospital mortality, 30-day readmission, and length of hospital stay after surgery for primary colorectal cancer: a national population-based study. Eur J Surg Oncol. 2017; 43:1312–23.
51.
HeY, Di LiangDL, ShiJ, et al.Cancer incidence and mortality in Hebei province, 2013. Medicine. 2017; 96(26):1–10.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
